PharVision Advisers’s Rapid7 RPD Stock Holding History

PharVision Advisers’s Portfolio RPD Stock Details RPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,872	Closed	-$109K	–	121
2026 Q1	$109K	Buy	+19,872	New	+$183K	1.11%	42

Other funds holding RPD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JPM

JANA Partners Management New York $1.9B AUM 18.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PharVision Advisers's RPD Position: Q2 2026 in Review

PharVision Advisers sold out of Rapid7 (RPD) in Q2 2026, closing a stake of 19,872 shares — an estimated $109K sold.

PharVision Advisers first reported a position in RPD in Q1 2026 and held it in 1 quarter. The position peaked at $109K in Q1 2026. 236 funds tracked by Wall St. Rank hold RPD as of Q2 2026.

PharVision Advisers reported no remaining Rapid7 position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 19,872 Rapid7 shares in Q2 2026, an estimated $109K.
PharVision Advisers first reported a position in Rapid7 in Q1 2026 and held it in 1 quarter.
PharVision Advisers's Rapid7 position peaked at $109K in Q1 2026.
236 funds tracked by Wall St. Rank held Rapid7 as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.